Cargando…

High-Density Lipoprotein Lipidomics and Mortality in CKD

RATIONALE & OBJECTIVE: Patients with chronic kidney disease (CKD) have dysfunctional high-density lipoprotein (HDL) particles that lack cardioprotective properties; altered lipid composition may be associated with these changes. To investigate HDL lipids as potential cardiovascular risk factors...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lidgard, Benjamin, Hoofnagle, Andrew N., Zelnick, Leila R., de Boer, Ian H., Fretts, Amanda M., Kestenbaum, Bryan R., Lemaitre, Rozenn N., Robinson-Cohen, Cassianne, Bansal, Nisha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507644/ https://www.ncbi.nlm.nih.gov/pubmed/37731962 http://dx.doi.org/10.1016/j.xkme.2023.100708

Ejemplares similares

Evaluation of plasma sphingolipids as mediators of the relationship between kidney disease and cardiovascular events
por: Lidgard, Benjamin, et al.
Publicado: (2023)

Vitamin D Metabolic Ratio and Risks of Death and CKD Progression
por: Bansal, Nisha, et al.
Publicado: (2019)

Impact of Removing Race Variable on CKD Classification Using the Creatinine-Based 2021 CKD-EPI Equation
por: Ghuman, Jasleen K., et al.
Publicado: (2022)

Vitamin D Metabolites and Risk of Cardiovascular Disease in Chronic Kidney Disease: The CRIC Study
por: Hsu, Simon, et al.
Publicado: (2023)

Serum Parathyroid Hormone and 25‐Hydroxyvitamin D Concentrations and Risk of Incident Heart Failure: The Multi‐Ethnic Study of Atherosclerosis
por: Bansal, Nisha, et al.
Publicado: (2014)

Physical activity and metabolic health in chronic kidney disease: a cross-sectional study
por: Bowlby, Wilson, et al.
Publicado: (2016)

Soluble ST2 and Galectin-3 and Progression of CKD
por: Alam, Mariam L., et al.
Publicado: (2018)

Association of FMO3 Variants and Trimethylamine N-Oxide Concentration, Disease Progression, and Mortality in CKD Patients
por: Robinson-Cohen, Cassianne, et al.
Publicado: (2016)

Framingham and American College of Cardiology/American Heart Association Pooled Cohort Equations, High‐Sensitivity Troponin T, and N‐Terminal Pro–Brain‐Type Natriuretic Peptide for Predicting Atherosclerotic Cardiovascular Events Across the Spectrum of Kidney Dysfunction
por: Lidgard, Benjamin, et al.
Publicado: (2022)

The serum 24,25-dihydroxyvitamin D concentration, a marker of vitamin D catabolism, is reduced in chronic kidney disease
por: Bosworth, Cortney, et al.
Publicado: (2012)

Tubular Secretion and Estimated GFR Decline in the Jackson Heart Study
por: Granda, Michael L., et al.
Publicado: (2022)

Metabolomics and Gene Expression Analysis Reveal Down-regulation of the Citric Acid (TCA) Cycle in Non-diabetic CKD Patients
por: Hallan, Stein, et al.
Publicado: (2017)

Cardiac Biomarkers and Risk of Mortality in CKD (the CRIC Study)
por: Wang, Ke, et al.
Publicado: (2020)

APOL1, Sickle Cell Trait, and CKD in the Jackson Heart Study
por: Young, Bessie A., et al.
Publicado: (2021)

Prediction of Incident Heart Failure in CKD: The CRIC Study
por: Zelnick, Leila R., et al.
Publicado: (2022)

Achievement of Low-Density Lipoprotein Cholesterol Targets in CKD
por: Massy, Ziad A., et al.
Publicado: (2019)

Potassium Measures and Their Associations with Glucose and Diabetes Risk: The Multi-Ethnic Study of Atherosclerosis (MESA)
por: Chatterjee, Ranee, et al.
Publicado: (2016)

Associations of Diet Quality and Blood Serum Lipoprotein Levels in a Population at High Risk for Diabetes: The Strong Heart Family Study
por: Kauffman, Sophie A.E., et al.
Publicado: (2019)

Biomarkers of Vitamin D Metabolism and Hip and Vertebral Fracture Risk: The Multi‐Ethnic Study of Atherosclerosis
por: Hsu, Simon, et al.
Publicado: (2022)

Dysfunctional High-Density Lipoprotein: An Innovative Target for Proteomics and Lipidomics
por: Salazar, Juan, et al.
Publicado: (2015)

Associations Between Cardiac Biomarkers and Cardiac Structure and Function in CKD
por: Stein, Nathan R., et al.
Publicado: (2020)

Association of the Estimated Glomerular Filtration Rate With vs Without a Coefficient for Race With Time to Eligibility for Kidney Transplant
por: Zelnick, Leila R., et al.
Publicado: (2021)

APOL1, Acid Load, and CKD Progression
por: Pike, Mindy, et al.
Publicado: (2019)

Plasma Ceramides and Sphingomyelins in Relation to Atrial Fibrillation Risk: The Cardiovascular Health Study
por: Jensen, Paul N., et al.
Publicado: (2020)

Paricalcitol does not improve glucose metabolism in patients with stage 3-4 chronic kidney disease
por: de Boer, Ian H., et al.
Publicado: (2012)

Circulating ceramides and sphingomyelins and the risk of incident cardiovascular disease among people with diabetes: the strong heart study
por: Jensen, Paul N., et al.
Publicado: (2022)

Plasma Ceramides and Sphingomyelins and Sudden Cardiac Death in the Cardiovascular Health Study
por: Bockus, Lee B., et al.
Publicado: (2023)

Plasma ceramides containing saturated fatty acids are associated with risk of type 2 diabetes
por: Fretts, Amanda M., et al.
Publicado: (2021)

Body Composition Changes Following Dialysis Initiation and Cardiovascular and Mortality Outcomes in CRIC (Chronic Renal Insufficiency Cohort): A Bioimpedance Analysis Substudy
por: Wang, Ke, et al.
Publicado: (2021)

Supervised Exercise Intervention and Overall Activity in CKD
por: Pike, Mindy M., et al.
Publicado: (2020)

Circulating sphingolipids, fasting glucose, and impaired fasting glucose: The Strong Heart Family Study
por: Jensen, Paul N., et al.
Publicado: (2018)

Kidney Function and Subclinical Arrhythmias: The Multi-Ethnic Study of Atherosclerosis
por: Wiggins, Kerri L., et al.
Publicado: (2021)

Circulating Sphingolipids, Insulin, HOMA-IR, and HOMA-B: The Strong Heart Family Study
por: Lemaitre, Rozenn N., et al.
Publicado: (2018)

Non-High-Density Lipoprotein Cholesterol and Progression of Chronic Kidney Disease: Results from the KNOW-CKD Study
por: Suh, Sang Heon, et al.
Publicado: (2022)

Magnesium and Cardiovascular Disease in CKD: The Mysteries of a Humble Divalent Cation
por: Kula, Alexander J., et al.
Publicado: (2021)

Susceptibility of low-density lipoprotein particles to aggregate depends on particle lipidome, is modifiable, and associates with future cardiovascular deaths
por: Ruuth, Maija, et al.
Publicado: (2018)

Glucose time in range and peripheral neuropathy in type 2 diabetes mellitus and chronic kidney disease
por: Mayeda, Laura, et al.
Publicado: (2020)

Incident Atrial Fibrillation and Risk of Dementia in a Diverse, Community‐Based Population
por: Bansal, Nisha, et al.
Publicado: (2023)

Non-High-Density Lipoprotein Cholesterol and Cardiovascular Outcomes in Chronic Kidney Disease: Results from KNOW-CKD Study
por: Suh, Sang Heon, et al.
Publicado: (2022)

A lipidome-wide association study of the lipoprotein insulin resistance index
por: Bagheri, Minoo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_131it8hki6igldbjk0ao3sujbl